About Us
  • Approach
  • Expertise
  • History
  • Leadership Team
  • People
  • Clients
  • Community
  • DChang

    Dennis Chang, a Principal at Clarion Healthcare, joined the firm after PhD and postdoctoral training in neuroscience and molecular genetics. During his 7 years at Clarion, he has blended his strong scientific expertise with commercial strategy to create insight and value for clients in oncology and other specialty markets where innovation is critical to success.  Dennis’ work spans the length and breadth of product development: he led the development of Clarion’s SPARC (Strategic Pathway Research in Cancer) offering as an opportunity assessment for early-stage pipeline products in oncology, and has also been deeply involved in market analysis and commercialization strategies for later-stage new products, translating market insights into actionable development and commercial strategies. Dennis has completed more than 60 projects, the majority of those in oncology.

    Dennis received a PhD from the Neurobiology Department at Harvard Medical School and held positions as a Postdoctoral Fellow at Brandeis University and as a Visiting Assistant Professor in the Biology Department at Wellesley College. He is the lead author of four peer-reviewed publications in molecular/cellular biology and neuroscience journals.

    Next: Robert Moy >> 

    Home | Contact | Terms & Conditions | Login

    © 2011 - Clarion Healthcare - All Rights Reserved